Indian Drug Company To Pay $50M For Hiding Records About Drug Impurities
LAS VEGAS — Indian drug maker Fresenius Kabi Oncology Ltd. on March 23 pleaded guilty to refusing to permit the Food and Drug Administration access to records at an Indian manufacturing...To view the full article, register now.
Already a subscriber? Click here to view full article